NL-OMON31197尚未招募4 期
Intravenous versus Subcutaneous Immunoglobuline therapy in Multifocal motor neuropathy - ISIM
适应症
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •All adult patients (??? 18 years) with signs and symptoms consistent with MMN that fulfill the EFNS/PNS criteria for definite MMN and are being treated with IVIg for at least 6 months at regular intervals of at most 6 weeks. Patients have to have stable disease for at least 6 months before inclusion.
排除标准
- •Use of drugs which are known to cause motor neuropathy
- •Patient and/or partner is/are unable to administer SCIg at home.
- •Other diseases known to cause neuropathy or to reduce mobility
- •Diseases known to lead to severe handicap or death at short notice
- •A known selective IgA deficiency with anti-IgA antibodies
- •Refusal to give informed consent or withdrawal of previously given permission
- •Legally incompetent adult
研究者
相似试验
已完成
不适用
Intravenous versus subcutaneous immunoglobulin therapy in multifocal motor neuropathyMotor neuron diseaseISRCTN66618743Academic Medical Centre (AMC) (The Netherlands)10
已完成
不适用
Comparison of the effect of Intravenous immunoglobulin and rhophylacIdiopathic thrombocytopenic purpura.Idiopathic thrombocytopenic purpura (Evans syndrome)IRCT2012102811289N1Arak University of Medical Sciences, Vice Chancellor for Research60
暂停
3 期
Intravenous immunoglobulin and intravenous methylprednisolone as optimal induction treatment in CIDP (OPTIC trial)10034606Chronic Inflammatory Demyelinating PolyneuropathyCIDPNL-OMON50340Academisch Medisch Centrum60
进行中（未招募）
1 期
Initial treatment of chronic inflammatory demyelinating polyneuropathy (CIDP) - combined immunoglobulin and steroid treatment versus immunoglobulin treatment alone.Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)MedDRA version: 21.1Level: PTClassification code 10057645Term: Chronic inflammatory demyelinating polyradiculoneuropathySystem Organ Class: 10029205 - Nervous system disordersEUCTR2017-002511-34-GBAcademic Medical Centre, Amsterdam,96
进行中（未招募）
1 期
Intravenous immunoglobulin and intravenous methylprednisolone as optimal induction treatment in CIDP(OPTIC trial)Chronic inflammatory demyelinating polyneuropathy (CIDP)EUCTR2017-002511-34-NLAcademisch Medisch Centrum96